does cigna cover glp-1 for weight loss reaches new deal on Eli Lilly and Novo Nordisk drugs Cigna dropping GLP-1 obesity drug
Description
These findings support the potential of amycretin as a promising treatment for overweight and obesity
The recurring themes are bundle pricing confusion (people charged $3,000+ thinking they were signing up monthly), a no-refund-once-shipped policy, and a cancellation process that requires a phone call with retention pressure
Unless you were a GLP-1 user before the Ozempic craze, you might've never heard about itlet alone considered using it
2023;572 doi: 10.1016/j.mce.2023.111954
Fitzgerald I, Sahm LJ, Byrne A, et al
